全文获取类型
收费全文 | 2541篇 |
免费 | 140篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 62篇 |
妇产科学 | 81篇 |
基础医学 | 310篇 |
口腔科学 | 26篇 |
临床医学 | 149篇 |
内科学 | 805篇 |
皮肤病学 | 31篇 |
神经病学 | 223篇 |
特种医学 | 54篇 |
外科学 | 381篇 |
综合类 | 5篇 |
预防医学 | 144篇 |
眼科学 | 19篇 |
药学 | 162篇 |
中国医学 | 4篇 |
肿瘤学 | 215篇 |
出版年
2023年 | 17篇 |
2022年 | 28篇 |
2021年 | 56篇 |
2020年 | 36篇 |
2019年 | 51篇 |
2018年 | 56篇 |
2017年 | 63篇 |
2016年 | 62篇 |
2015年 | 79篇 |
2014年 | 95篇 |
2013年 | 115篇 |
2012年 | 169篇 |
2011年 | 163篇 |
2010年 | 106篇 |
2009年 | 76篇 |
2008年 | 152篇 |
2007年 | 150篇 |
2006年 | 124篇 |
2005年 | 142篇 |
2004年 | 139篇 |
2003年 | 111篇 |
2002年 | 104篇 |
2001年 | 66篇 |
2000年 | 59篇 |
1999年 | 44篇 |
1998年 | 25篇 |
1997年 | 22篇 |
1996年 | 24篇 |
1995年 | 12篇 |
1994年 | 9篇 |
1993年 | 20篇 |
1992年 | 42篇 |
1991年 | 27篇 |
1990年 | 18篇 |
1989年 | 22篇 |
1988年 | 23篇 |
1987年 | 13篇 |
1986年 | 15篇 |
1985年 | 22篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 7篇 |
1980年 | 10篇 |
1979年 | 20篇 |
1978年 | 10篇 |
1977年 | 12篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1972年 | 7篇 |
排序方式: 共有2697条查询结果,搜索用时 15 毫秒
101.
Manuel Cappellari Giuseppe Moretto Nicola Micheletti Francesco Donato Giampaolo Tomelleri Giosuè Gulli Monica Carletti Giovanna Maddalena Squintani Tiziano Zanoni Sarah Ottaviani Silvia Romito Giorgio Tommasi Anna Maria Musso Luciano Deotto Giuseppe Gambina Domenico Sergio Zimatore Paolo Bovi 《Journal of thrombosis and thrombolysis》2014,37(4):549-556
According to current European Alteplase license, therapeutic-window for intravenous (IV) thrombolysis in acute ischemic stroke has recently been extended to 4.5 h after symptoms onset. However, due to numerous contraindications, the portion of patients eligible for treatment still remains limited. Early neurological status after thrombolysis could identify more faithfully the impact of off-label Alteplase use that long-term functional outcome. We aimed to identify the impact of off-label thrombolysis and each off-label criterion on early clinical outcomes compared with the current European Alteplase license. We conducted an analysis on prospectively collected data of 500 consecutive thrombolysed patients. The primary outcome measures included major neurological improvement (NIHSS score decrease of ≤8 points from baseline or NIHSS score of 0) and neurological deterioration (NIHSS score increase of ≥4 points from baseline or death) at 24 h. We estimated the independent effect of off-label thrombolysis and each off-label criterion by calculating the odds ratio (OR) with 2-sided 95 % confidence interval (CI) for each outcome measure. As the reference, we used patients fully adhering to the current European Alteplase license. 237 (47.4 %) patients were treated with IV thrombolysis beyond the current European Alteplase license. We did not find significant differences between off- and on-label thrombolysis on early clinical outcomes. No off-label criteria were associated with decreased rate of major neurological improvement compared with on-label thrombolysis. History of stroke and concomitant diabetes was the only off-label criterion associated with increased rate of neurological deterioration (OR 5.84, 95 % CI 1.61–21.19; p = 0.024). Off-label thrombolysis may be less effective at 24 h than on-label Alteplase use in patients with previous stroke and concomitant diabetes. Instead, the impact of other off-label criteria on early clinical outcomes was not different compared with current European Alteplase license. 相似文献
102.
Gaggiano Carla Rigante Donato Tosi Gian Marco Vitale Antonio Frediani Bruno Grosso Salvatore Fabiani Claudia Cantarini Luca 《Clinical rheumatology》2020,39(2):327-337
Clinical Rheumatology - Chronic anterior uveitis is the most frequent among extra-articular manifestations of juvenile idiopathic arthritis (JIA) and a relevant cause of ocular morbidity in... 相似文献
103.
Massimo Martino Mercedes Gori Giovanni Tripepi Anna Grazia Recchia Michele Cimminiello Pasquale Fabio Provenzano Virginia Naso Anna Ferreri Tiziana Moscato Giuseppe Console Barbara Loteta Giuseppe Alberto Gallo Massimo Gentile Vanessa Innao Marco Rossi Antonella Morabito Iolanda Donatella Vincelli Donato Mannina Annalisa Pitino 《Annals of hematology》2020,99(2):331-341
G-CSF administration after high-dose chemotherapy and autologous stem cell transplantation (ASCT) has been shown to expedite neutrophil recovery. Several studies comparing filgrastim and pegfilgrastim in the post-ASCT setting concluded that the two are at least equally effective. Lipegfilgrastim (LIP) is a new long-acting, once-per-cycle G-CSF. This multicentric, prospective study aimed to describe the use of LIP in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation (ASCT) and compare LIP with historic controls of patients who received short-acting agent (filgrastim [FIL]). Overall, 125 patients with a median age of 60 years received G-CSF after ASCT (80 patients LIP on day 1 post-ASCT and 45 patients FIL on day 5 post-ASCT). The median duration of grade 4 neutropenia (absolute neutrophil count [ANC] < 0.5 × 10 [9]/L) was 5 days in both LIP and FIL groups, whereas the median number of days to reach ANC ≥ 0.5 × 10 [9]/L was 10% lower in the LIP than in the FIL group (10 vs 11 days), respectively. Male sex was significantly associated with a faster ANC ≥ 0.5 × 10 [9] L response (p = 0.015). The incidence of FN was significantly lower in the LIP than in the FIL group (29% vs 49%, respectively, p = 0.024). The days to discharge after ASCT infusion were greater in patients with FN (p < 0.001). The study indicates that LIP had a shorter time to ANC recovery and is more effective than FIL for the prevention of FN in the ASCT setting. 相似文献
104.
105.
Paolo Rigotti Giovanni Capovilla Caterina Di Bella Cristina Silvestre Paola Donato Nicola Baldan Lucrezia Furian 《Clinical transplantation》2014,28(12):1433-1440
This study reports on a large series of 200 dual kidney transplantations (DKTs) from expanded criteria donors (ECDs) and proposes specific ways to optimize outcomes. Data concerning 200 DKTs performed in the last 14 yr were retrospectively analyzed. Kidneys from high‐risk ECD were allocated for use in DKTs on an old‐for‐old basis after histological assessment. Different surgical techniques and immunosuppressant regimens were used over time, and the outcomes are discussed. Donors and recipients were a median 73 (70–77) and a 62 (58–67) yr old, respectively. Delayed graft function occurred in 31.5% of cases, and acute rejection in 13.5%. Patient and graft survival at five yr were 90.4% and 85.8%, respectively. Unilateral kidney placement was preferred for 75% of patients, and was associated with a low rate of surgical complications. Our current standard therapy comprising low‐dose calcineurin inhibitors (CNIs) associated with mammalian target of rapamycin inhibitors (mTOR) and steroids appears to offer the best risk/benefit profile for elderly patients undergoing DKT. In our experience, outcomes after DKT can be improved by: (i) kidney clinical–histological assessment; (ii) unilateral kidney placement; (iii) minimal use of CNI associated with mTOR. 相似文献
106.
Donato Casella Marco Bernini Lapo Bencini Jenny Roselli Maria Teresa Lacaria Jacopo Martellucci Roberto Banfi Claudio Calabrese Lorenzo Orzalesi 《European journal of plastic surgery》2014,37(11):599-604
Background
Immediate implant reconstruction after a conservative mastectomy is an attractive option made easier by prosthetic devices. Titanized polypropylene meshes are used as a hammock to cover the lower lateral implant pole. We conducted a prospective nonrandomized single-institution study of reconstructions using titanium-coated meshes either in a standard muscular mesh pocket or in a complete subcutaneous approach. The complete subcutaneous approach means to wrap an implant with titanized mesh in order to position the implant subcutaneously and spare muscles.Methods
Between November 2011 and January 2014, we performed immediate implant breast reconstructions after conservative mastectomies using TiLoop® Bra, either with the standard retropectoral or with a prepectoral approach. Selection criteria included only women with normal Body Mass Index (BMI), no large and very ptotic breasts, no history of smoking, no diabetes, and no previous radiotherapy. We analyzed short-term outcomes of such procedures and compared the outcomes to evaluate implant losses and surgical complications.Results
A total of 73 mastectomies were performed. Group 1 comprised 29 women, 5 bilateral procedures, 34 reconstructions, using the standard muscular mesh pocket. Group 2 comprised 34 women, 5 bilateral procedures, 39 reconstructions with the prepectoral subcutaneous technique. Baseline and oncologic characteristics were homogeneous between the two groups. After a median follow-up period of 13 and 12 months, respectively, no implant losses were recorded in group 1, and one implant loss was recorded in group 2. We registered three surgical complications in group 1 and two surgical complications in group 2.Conclusions
Titanium-coated polypropylene meshes, as a tool for immediate definitive implant breast reconstruction, resulted as safe and effective in a short-term analysis, both for a retropectoral and a totally subcutaneous implant placement. Long-term results are forthcoming. A strict selection is mandatory to achieve optimal results. Level of Evidence: Level II, therapeutic study. 相似文献107.
108.
Donatella Paolino Donato Cosco Marco Gaspari Marilena Celano Joy Wolfram Pasquale Voce Efisio Puxeddu Sebastiano Filetti Christian Celia Mauro Ferrari Diego Russo Massimo Fresta 《Biomaterials》2014
Various tissue-specific antibodies have been attached to nanoparticles to obtain targeted delivery. In particular, nanodelivery systems with selectivity for breast, prostate and cancer tissue have been developed. Here, we have developed a nanodelivery system that targets the thyroid gland. Nanoliposomes have been conjugated to the thyroid-stimulating hormone (TSH), which binds to the TSH receptor (TSHr) on the surface of thyrocytes. The results indicate that the intracellular uptake of TSH-nanoliposomes is increased in cells expressing the TSHr. The accumulation of targeted nanoliposomes in the thyroid gland following intravenous injection was 3.5-fold higher in comparison to untargeted nanoliposomes. Furthermore, TSH-nanoliposomes encapsulated with gemcitabine showed improved anticancer efficacy in vitro and in a tumor model of follicular thyroid carcinoma. This drug delivery system could be used for the treatment of a broad spectrum of thyroid diseases to reduce side effects and improve therapeutic efficacy. 相似文献
109.
Arwyn Evans Matthew Cummings Donato Decarolis Diego Gianolio Salman Shahid Gareth Law Martin Attfield David Law Camille Petit 《RSC advances》2020,10(9):5152
Carbon monoxide (CO) purification from syngas impurities is a highly energy and cost intensive process. Adsorption separation using metal–organic frameworks (MOFs) is being explored as an alternative technology for CO/nitrogen (N2) and CO/carbon dioxide (CO2) separation. Currently, MOFs'' uptake and selectivity levels do not justify displacement of the current commercially available technologies. Herein, we have impregnated a leading MOF candidate for CO purification, i.e. M-MOF-74 (M = Co or Ni), with Cu+ sites. Cu+ allows strong π-complexation from the 3d electrons with CO, potentially enhancing the separation performance. We have optimised the Cu loading procedure and confirmed the presence of the Cu+ sites using X-ray absorption fine structure analysis (XAFS). In situ XAFS and diffuse reflectance infrared Fourier Transform spectroscopy analyses have demonstrated Cu+–CO binding. The dynamic breakthrough measurements showed an improvement in CO/N2 and CO/CO2 separations upon Cu impregnation. This is because Cu sites do not block the MOF metal sites but rather increase the number of sites available for interactions with CO, and decrease the surface area/porosity available for adsorption of the lighter component.We present an in situ study of CO adsorption on Cu impregnated MOF-74 and study the competitive adsorption of CO vs. CO2 and N2. 相似文献
110.